These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 8412962)
1. No role for short term tuberculosis chemoprophylaxis for travellers. Plant AJ; MacIntyre CR Med J Aust; 1993 Oct; 159(8):563-4. PubMed ID: 8412962 [No Abstract] [Full Text] [Related]
2. New UK guidance on the prevention and control of transmission of HIV related and drug resistant tuberculosis. Commun Dis Rep CDR Wkly; 1999 Feb; 9(6):49. PubMed ID: 10024752 [No Abstract] [Full Text] [Related]
3. Preventive therapy for tuberculosis in HIV infection: the promise and the reality. O'Brien RJ; Perriëns JH AIDS; 1995 Jul; 9(7):665-73. PubMed ID: 7546409 [TBL] [Abstract][Full Text] [Related]
4. [Tuberculosis--still a problem?]. Magnussen H Fortschr Med; 1995 Mar; 113(9):1. PubMed ID: 7759040 [No Abstract] [Full Text] [Related]
6. New developments in tuberculosis and HIV infection: an opportunity for prevention. Curtis JR; Hooton TM; Nolan CM J Gen Intern Med; 1994 May; 9(5):286-94. PubMed ID: 8046533 [TBL] [Abstract][Full Text] [Related]
7. Tuberculosis and HIV infection. Bevilacqua N; Marasca G; Moscati A; Fantoni M; Ricci F; Ortona L Lancet; 1993 Sep; 342(8872):677. PubMed ID: 8103158 [No Abstract] [Full Text] [Related]
8. Isoniazid prophylaxis for high-risk patients with anergy and HIV infection. Aguado JM; Pulido F; Moreno S N Engl J Med; 1997 Dec; 337(23):1696-7; author reply 1697. PubMed ID: 9411240 [No Abstract] [Full Text] [Related]
9. On consumption. Welty TK; Volmer L S D J Med; 1994 Sep; 47(9):326. PubMed ID: 7973600 [No Abstract] [Full Text] [Related]
10. Isoniazid prevented active tuberculosis in patients with HIV treated with antiretroviral therapy. Sacks HS Ann Intern Med; 2014 Sep; 161(6):JC12. PubMed ID: 25222412 [No Abstract] [Full Text] [Related]
11. Isoniazid prophylaxis for high-risk patients with anergy and HIV infection. Dore GJ; Law MG; Kaldor JM N Engl J Med; 1997 Dec; 337(23):1697. PubMed ID: 9411241 [No Abstract] [Full Text] [Related]
12. Tuberculosis prophylaxis in HIV infection. Trevett A; Temu P; Naraqi S P N G Med J; 1993 Sep; 36(3):256. PubMed ID: 8059554 [No Abstract] [Full Text] [Related]
13. Preventive treatment for tuberculosis in people with HIV. Swaminathan S Lancet; 2014 Aug; 384(9944):644-6. PubMed ID: 24835843 [No Abstract] [Full Text] [Related]
14. Tuberculosis preventive therapy in HIV-infected individuals. A Joint Statement of the WHO Tuberculosis Programme and the Global Programme on AIDS, and the International Union Against Tuberculosis and Lung Disease (IUATLD). Wkly Epidemiol Rec; 1993 Dec; 68(49):361-4. PubMed ID: 8292529 [No Abstract] [Full Text] [Related]
15. Isoniazid chemoprophylaxis for dual HIV-TB infection: a cautionary tale. FitzGerald JM Can Commun Dis Rep; 1995 Feb; 21(4):29-32; discussion 32, 35. PubMed ID: 7735192 [No Abstract] [Full Text] [Related]
16. Influence of the human immunodeficiency virus in the incidence of tuberculosis in a cohort of intravenous drug users: effectiveness of anti-tuberculosis chemoprophylaxis. Jansà JM; Serrano J; Caylà JA; Vidal R; Ocaña I; Español T Int J Tuberc Lung Dis; 1998 Feb; 2(2):140-6. PubMed ID: 9580481 [TBL] [Abstract][Full Text] [Related]
17. The threat of multidrug resistance: is tuberculosis ever untreatable or uncontrollable? Gleissberg V Lancet; 1999 Mar; 353(9157):998-9. PubMed ID: 10459924 [No Abstract] [Full Text] [Related]
18. Questions about a placebo-controlled trial of preventive therapy for tuberculosis in HIV-infected Ugandans. Desvarieux M N Engl J Med; 1998 Mar; 338(12):841; author reply 842-3. PubMed ID: 9508639 [No Abstract] [Full Text] [Related]